Home / Economy / Dr Reddy#39;s stock surges 6% on receiving EIR from USFDA

Dr Reddy#39;s stock surges 6% on receiving EIR from USFDA


Dr Reddy#39;s stock surges 6% on receiving EIR from USFDA The company yesterday said it has received an EIR from USFDA on December 11 as closure of audit for its formulations manufacturing plant – 3 at Bachupally, Hyderabad. Dr Reddy#39;s was issued a form 483 with 11 observations.